Is Tenofovir Superior to Entecavir in Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B? The Controversy Continues

被引：10
|
作者：
Lampertico, Pietro [1 ]
Papatheodoridis, George V. [2 ]
机构：
[1] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, CRC AM & A Migliavacca Ctr Study Liver Dis, Via F Sforza 35, I-20122 Milan, Italy
[2] Univ Athens, Sch Med, Dept Gastroenterol, Gen Hosp Athens Laiko, Athens, Greece
来源：
GASTROENTEROLOGY | 2020年 / 158卷 / 01期
关键词：
DISOPROXIL FUMARATE; HCC; THERAPY;
D O I：
10.1053/j.gastro.2019.11.007
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：42 / 44
页数：4
相关论文
共 50 条
  • [1] Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B?
    Yuan, Bao-Hong
    Zhu, Yan-Kun
    Li, Ru-Hong
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (02) : 314 - 315
  • [2] Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B
    Choi, Won-Mook
    Choi, Jonggi
    Wong, Grace Lai-Hung
    Han, Seungbong
    Lim, Young-Suk
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (02): : 87 - 87
  • [3] Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
    Lee, Han Ah
    Seo, Yeon Seok
    Kim, Seung Up
    GASTROENTEROLOGY, 2020, 158 (08) : 2310 - 2311
  • [4] Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors' reply
    Yip, Terry C. -F.
    Wong, Grace L. -H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (02) : 315 - 316
  • [5] Is tenofovir disoproxil fumarate superior to entecavir for prevention of hepatocellular carcinoma in patients with chronic hepatitis B?
    van Velsen, Lisa M.
    Sonneveld, Milan J.
    van Erpecum, Karel J.
    HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (06) : 919 - 922
  • [6] Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
    Liu, Zhihong
    Sun, Jian
    Hou, Jinlin
    JAMA ONCOLOGY, 2019, 5 (06) : 915 - 915
  • [7] Hepatitis B: Tenofovir is superior than Entecavir for treating Patients with Hepatocellular Carcinoma
    Lorenz, Judith
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (08):
  • [8] Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir
    Hsu, Yao-Chun
    Ho, Hsiu-J.
    Lee, Teng-Yu
    Huang, Yen-Tsung
    Wu, Ming-Shiang
    Lin, Jaw-Town
    Wu, Chun-Ying
    El-Serag, Hashem B.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (05) : 543 - 551
  • [9] Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B Reply
    Choi, Jonggi
    Ko, Min Jung
    Lim, Young-Suk
    JAMA ONCOLOGY, 2019, 5 (06) : 916 - 917
  • [10] Is Tenofovir Associated with a Lower Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Compared With Entecavir?
    Kamal, Faisal
    Khan, Muhammad Ali
    GASTROENTEROLOGY, 2020, 158 (08) : 2311 - 2312
12345